|
|
Volumn , Issue , 2013, Pages
|
|
Update on the initial therapy of multiple myeloma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR MARKER;
ADJUVANT THERAPY;
ADVERSE EFFECTS;
AGE;
DISEASE FREE SURVIVAL;
DRUG DESIGN;
GENETICS;
HUMAN;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
MORTALITY;
MULTIPLE MYELOMA;
PATHOLOGY;
PATIENT SELECTION;
RISK FACTOR;
SIGNAL TRANSDUCTION;
STEM CELL TRANSPLANTATION;
TIME;
TREATMENT OUTCOME;
AGE FACTORS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DISEASE-FREE SURVIVAL;
DRUG DESIGN;
HUMANS;
MOLECULAR TARGETED THERAPY;
MULTIPLE MYELOMA;
NEOADJUVANT THERAPY;
PATIENT SELECTION;
RISK FACTORS;
SIGNAL TRANSDUCTION;
STEM CELL TRANSPLANTATION;
TIME FACTORS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 84946225966
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.1200/EdBook_AM.2013.33.e307 Document Type: Review |
|
Times cited : (6)
|
|
References (0)
|